REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 2nd, 2012 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 29, 2012, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the “Company”), and DELTA DENTAL PLAN OF MICHIGAN, INC., a Michigan nonprofit corporation (the “Shareholder”). Unless otherwise defined herein, all capitalized terms used herein shall have the meanings ascribed to them in that certain Stock Purchase Agreement, dated as of even date herewith, by and among the Company and the Shareholder (the “Purchase Agreement”).
STOCK PURCHASE AGREEMENT by and between Interleukin Genetics, Inc. and Delta Dental Plan of Michigan, Inc. June 29, 2012Stock Purchase Agreement • July 2nd, 2012 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
This Stock Purchase Agreement (this “Agreement”) dated as of June 29, 2012 is made by and between Interleukin Genetics, Inc., a Delaware corporation, (the “Company”), and Delta Dental Plan of Michigan, Inc., a Michigan nonprofit corporation (the “Purchaser”).
EXCHANGE AGREEMENTExchange Agreement • July 2nd, 2012 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
This Exchange Agreement (the “Agreement”) is entered into this 29th day of June, 2012 by and among Interleukin Genetics, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Pyxis Innovations Inc. (“Pyxis”).
FOURTH AMENDMENT TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • July 2nd, 2012 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
This FOURTH AMENDMENT TO AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (the “Amendment”), dated and effective as of June 29, 2012, by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the “Company”), and PYXIS INNOVATIONS INC., a Delaware corporation (“Pyxis”).
THIRD AMENDMENT TO TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 2nd, 2012 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
This THIRD AMENDMENT TO STOCK PURCHASE AGREEMENT (this “Amendment”) is entered into as of this 29th day of June 2012, by and among Interleukin Genetics, Inc., a Delaware corporation (the “Company”), and Pyxis Innovations Inc., a Delaware corporation (“Pyxis”). Unless otherwise defined in this Amendment, capitalized terms used herein shall have the respective meanings ascribed thereto in the Stock Purchase Agreement (defined below).
